Medicated Feed Additives Market Report 2026

The medicated feed additives market size has grown steadily in recent years. It will grow from $14.3 billion in 2025 to $15.01 billion in 2026 at a compound annual growth rate (CAGR) of 5%. The growth in the historic period can be attributed to widespread use of antibiotics in animal feed, growth in intensive livestock farming, increasing prevalence of parasitic and bacterial diseases, demand for improved feed efficiency, availability of standardized feed additive formulations.

The medicated feed additives market size is expected to see strong growth in the next few years. It will grow to $18.82 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to tightening regulations on antibiotic usage, rising demand for sustainable animal production, growth of functional feed additives, increasing focus on animal immunity and gut health, expansion of aquaculture and poultry sectors. Major trends in the forecast period include increasing use of medicated feed for disease prevention, rising demand for non-therapeutic growth enhancement alternatives, growing adoption of probiotic and prebiotic feed additives, expansion of premix and concentrate-based feed solutions, increasing focus on feed-based health management programs.

The increasing adoption of livestock farming is expected to drive the growth of the medicated feed additives market in the coming years. Livestock farming, also referred to as animal husbandry, involves the breeding, raising, and management of domesticated animals for multiple purposes. This adoption is rising due to the growing demand for animal-based food products, as farmers expand production to meet consumption needs and enhance income stability. Medicated feed additives are essential in livestock farming to prevent and control diseases, improve animal health, enhance growth and performance, optimize nutrition, reduce mortality, and increase feed utilization efficiency. For example, in October 2024, Eurostat, a Luxembourg-based government agency, reported that in 2023, the European Union's livestock population included 133 million pigs, 74 million bovines, and 68 million sheep and goats. Furthermore, EU poultry meat production reached 13.3 million tonnes in 2023, up from 13 million tonnes in 2022. Thus, the growing adoption of livestock farming is contributing to the expansion of the medicated feed additives market.

Leading players are focusing on developing innovative products, such as new active ingredients, to remain competitive in the market. New active ingredients are newly developed or enhanced bioactive compounds designed to improve the efficacy, safety, or performance of animal health and nutrition products. For instance, in June 2023, Evonik Industries, a Germany-based chemical manufacturer, launched an updated version of its Biolys product for animal feed. This improved formulation provides a higher concentration of L-lysine, an essential amino acid critical for optimal nutrition in pigs and poultry. The new Biolys formulation offers a more efficient source of L-lysine, supporting better growth and feed efficiency in livestock. Evonik's advancements in Biolys technology highlight its commitment to sustainability, efficiency, and enhanced nutritional benefits in animal feed.

In April 2024, Phibro Animal Health Corp., a US-based pharmaceutical manufacturing company, acquired Zoetis Inc. for $350 million. This acquisition supports Zoetis' strategic capital reallocation, enabling the company to concentrate on its core areas, including vaccines and biologics for animal health. Zoetis Inc. specializes in animal health products, providing a wide range of solutions for both companion animals and livestock, including medicines, vaccines, diagnostic products, and medicated feed additives.

Major companies operating in the medicated feed additives market are Zoetis Services LLC, Purina Animal Nutrition LLC, Alltech, Zagro Corporation, Biostadt Limited, Nutreco NV, Phibro Animal Health Corporation, Chr. Hansen A/S, NOSAN CORPORATION, Kemin Industries Inc., Provimi Holding BV, Lallemand Inc., Novus International Inc., Trouw Nutrition International B.V., Elanco Animal Health Incorporated, Merck Animal Health, Adisseo Group, Huvepharma EOOD, Boehringer Ingelheim Animal Health GmbH, Virbac SA, Ceva Santé Animale S.A., Addcon, Nutriad, Biovet SA, De Heus Animal Nutrition, MSD Animal Health, Bayer Animal Health.

Asia-Pacific was the largest region in the medicated feed additives market in 2025. The regions covered in the medicated feed additives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medicated feed additives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the medicated feed additives market by increasing the cost of imported antibiotics, vitamins, enzymes, and premix ingredients, leading to higher feed formulation expenses. Poultry, swine, and aquaculture segments in Asia-Pacific and Latin America are most affected due to dependence on cross-border supply chains. However, tariffs have supported local production of feed additives, encouraged regional sourcing of raw materials, and accelerated innovation in alternative additives such as probiotics and phytogenics, strengthening long-term market resilience.

The medicated feed additives market research report is one of a series of new reports that provides medicated feed additives market statistics, including medicated feed additives industry global market size, regional shares, competitors with a medicated feed additives market share, detailed medicated feed additives market segments, market trends and opportunities, and any further data you may need to thrive in the medicated feed additives industry. This medicated feed additives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medicated feed additives encompass feeds that contain one or more drugs intended to enhance the health and productivity of animals. Animals receive medicated feed additives for various purposes, such as nutrition, medication, management of worms, bacterial diseases, and coccidiosis, as well as for preventing mortality.

The primary types of medicated feed additives include antibiotics, vitamins, antioxidants, amino acids, prebiotics, probiotics, enzymes, and others. Antibiotics are medications used both for the prevention and treatment of bacterial infections. These additives are administered to various animal types, including ruminants, swine, poultry, aquaculture, and others, using a variety of mixture types such as supplements, concentrates, premixes, and base mixes.

The medicated feed additives market consists of sales of lonophores, buffers, yeast cultures, and bloat-prevention aids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.